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Background: The question of whether DNA obtained from saliva is an acceptable alternative to DNA from blood is
a topic of considerable interest for large genetics studies. We compared the yields, quality and performance of
DNAs from saliva and blood from a mostly elderly study population.
Methods: Two thousand nine hundred ten DNAs from primarily elderly subjects (mean age ± standard deviation
(SD): 65 ± 12 years), collected for the Primary Open-Angle African-American Glaucoma Genetics (POAAGG) study,
were evaluated by fluorometry and/or spectroscopy. These included 566 DNAs from blood and 2344 from saliva.
Subsets of these were evaluated by Sanger sequencing (n = 1555), and by microarray SNP genotyping (n = 94) on
an Illumina OmniExpress bead chip platform.
Results: The mean age of subjects was 65, and 68 % were female in both the blood and saliva groups. The
mean ± SD of DNA yield per ml of requested specimen was significantly higher for saliva (17.6 ± 17.8 μg/ml)
than blood (13.2 ± 8.5 μg/ml), but the mean ± SD of total DNA yield obtained per saliva specimen (35 ± 36 μg from
2 ml maximum specimen volume) was approximately three-fold lower than from blood (106 ± 68 μg from 8 ml
maximum specimen volume). The average genotyping call rates were >99 % for 43 of 44 saliva DNAs and >99 % for
50 of 50 for blood DNAs. For 22 of 23 paired blood and saliva samples from the same individuals, the average
genotyping concordance rate was 99.996 %. High quality PCR Sanger sequencing was obtained from≥ 98 % of blood
(n = 297) and saliva (n = 1258) DNAs. DNA concentrations ≥10 ng/μl, corresponding to total yields≥ 2 μg, were
obtained for 94 % of the saliva specimens (n = 2344).
Conclusions: In spite of inferior purity, the performance of saliva DNAs for microarray genotyping was excellent. Our
results agree with other studies concluding that saliva collection is a viable alternative to blood. The potential to boost
study enrollments and reduce subject discomfort is not necessarily offset by a reduction in genotyping efficiency.
Saliva DNAs performed comparably to blood DNAs for PCR Sanger sequencing.
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Large epidemiological studies with thousands of partici-
pants are increasingly supplementing survey data with
genomic DNA [1]. These studies require a simple, non-
invasive method of sample collection that yields genomic
DNA of adequate quality and quantity for high-
throughput technologies [2]. Blood has traditionally been
the primary source of genomic DNA, but saliva collec-
tion has recently emerged as a viable alternative [2, 3].
In addition to being less invasive, saliva collection has a
lower overall cost, lower risk of infection, and simpler
logistics. Stabilized saliva specimens can be stored at
ambient temperatures for months, whereas blood must
be frozen for long term storage, and protected from
freeze/thaw cycles [2, 4]. Unlike blood collection, saliva
collection does not require a trained phlebotomist; sub-
jects need only to be provided simple directions, and
may even donate saliva specimens by mail. These char-
acteristics facilitate community outreach efforts by
reducing costs for personnel training and effort, and
eliminate the logistical complexities associated with
transporting highly perishable blood specimens from re-
mote locations. Saliva collection also leads to signifi-
cantly higher response rates [1, 5], with one study
finding a 72 % response rate for saliva collection versus
31 % for blood draws [1]. Another advantage is that sal-
iva DNA has the potential to provide information about
the oral microbiome. Despite these advantages, there is
still reluctance among the scientific community to use
saliva samples, which largely stems from concerns over
reduced yield and quality of DNA [6–12].
Most studies agree that oral specimens yield lower
quantities of DNA compared to blood [2, 4, 13, 14].
DNA isolated from saliva samples is often contaminated
by foreign DNA from bacteria, fungi, and food remnants
[2, 13, 15]. Non-human DNA content from saliva sam-
ples varies greatly among patients, with studies reporting
non-human DNA yields ranging from 23 to 63 % of total
DNA [16]. Despite concerns over low yield and variabil-
ity among samples, previous studies have found that
saliva collection still provides sufficient DNA for geno-
typing [1, 2, 4, 15, 17].
Research on the usability of saliva samples from older
age groups remains limited, however. Subject age deter-
mines, in part, the number of epithelial cells found in
saliva [18, 19]. A previous study found a strong positive
correlation between subject age and DNA concentration
from saliva samples, with children under age 12 having
the lowest DNA concentration [18]. It is important to
extend this research to older populations, as the elderly
may have veins that are difficult to access for blood col-
lection [2]. Additionally, saliva collection has been
shown to reduce anxiety and increase participation rates
in older participants [2]. Negative correlation betweenblood DNA yield and subject age was reported in a large
prospective study by Caboux et al by assessing EPIC re-
cords of 50,000 subject DNA yields isolated from blood,
14 % of whom were ≥ 65 [20]. However, saliva collection
in the elderly requires further investigation, as hyposali-
vation can interfere with specimen collection in this age
group. Dry mouth has an incidence rate of 30 % in indi-
viduals over age 65 [21].
The Primary Open-Angle African-American Glaucoma
Genetics (POAAGG) study cohort is the largest African-
African primary-open angle glaucoma cohort recruited
at a single institution (University of Pennsylvania, De-
partment of Ophthalmology, Scheie Eye Institute) to
date [22]. The growing size of the cohort (n = 5300),
older age of POAAGG subjects, improvements in saliva
stabilization technologies, and reductions in the amount
of DNA needed for next-generation sequencing and
genotyping applications have led us to consider saliva
collection as the primary method for future subjects.
The objective of this study is to examine how well DNA
isolated from saliva samples performs, compared to
DNA from blood, for array-based genotyping and se-
quencing. These results will inform the future method of
DNA collection for the POAAGG study, as well as other
large-scale studies requiring genomic DNA from older
populations.
Methods
Subject recruitment and specimen collection
The POAAGG study is a five-year population-based pro-
ject funded by the National Eye Institute of the National
Institutes of Health. The study population consists of
self-identified Blacks (African Americans, African des-
cent, or African Caribbean). Although subjects as young
as age 35 are potentially eligible, primary open-angle
glaucoma is typically a disease of old age. Accordingly,
enrollment efforts for controls have also preferentially
targeted an older population, and the mean age of
POAAAGG subjects is approximately 65. POAAGG sub-
jects were recruited from the University of Pennsylvania
from the Scheie Eye Institute, The Perelman Center for
Advanced Medicine, and the Mercy Fitzgerald Hospital
Ophthalmology satellite. All subjects provided informed
written consent, in accordance with the tenets of the
Declaration of Helsinki, under University of Pennsylvania
IRB-approved protocol 815033.
Blood was collected by venipuncture in 10 ml purple
top tubes with EDTA anticoagulant. The maximum vol-
ume of blood collected was 8 ml per tube, but sometimes
less was obtained. These samples were frozen at −20° prior
to DNA isolation. For saliva collection, subjects were
asked to refrain from drinking or eating 30 min prior to
donating specimens and to remove lipstick. Subjects ex-
periencing dry mouth or difficulties with salivation were
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motion to stimulate the salivary glands. Subjects strug-
gling with hyposalivation were also offered packets of
sugar, or a sugar substitute, and told to place a small
amount on their tongues to induce salivation. A max-
imum volume of 2 ml of saliva per subject was collected
in Oragene DISCOVER (OGR-500) self-collection kits
(DNA Genotek, Canada), because we found that deliver-
ing more than one 2 ml saliva specimen in a single sitting
was challenging for subjects, but most subjects were able
to deliver this volume within a few minutes. The saliva
specimens were mixed with stabilizing reagent within the
collection tubes per manufacturer’s instructions, and these
were stored at room temperature until DNA extraction.
DNA extraction
DNA was isolated from freshly thawed blood samples
using Gentra PureGene kits (Qiagen, Valencia, CA), and
the optional RNase treatment step was included. DNA
from saliva samples was extracted using the prepIT.L2P
reagent (cat # PT-L2P-5, DNA Genotek, Canada) and
precipitated with ethanol according to manufacturer’s
instructions. The saliva DNA samples were RNAse
treated by double digestion with RNase A and RNase T
and re-precipitated using ethanol according to manufac-
turer’s instructions.
DNA quantitation and sample selection
The concentrations of DNA from blood and saliva sam-
ples were determined using the fluorescence-based
Quant iT dsDNA Board-Range (BR) assay kit (cat # Q-
33130, Life Technologies, CA). Fluorescence was mea-
sured with a Tecan Infinite M 200 Pro multimode mi-
croplate reader (Tecan, NC). Two thousand nine
hundred ten DNAs (566 from blood and 2344 from sal-
iva) from the POAAGG cohort were used to evaluate
DNA yields. During November 2014 the POAAGG
study switched to from blood to saliva as the primary
means of specimen collection, and all available saliva
DNAs obtained since then were included. Blood DNAs
which had been quantified using Nanodrop spectropho-
tometry were excluded from analysis to control for po-
tential bias from different quantitation methods. DNA
quantification by UV spectrometry may be confounded
by RNA or other contamination, and may systematically
overestimate DNA concentration. Accordingly, only the
blood and saliva samples that had been quantified by the
same automated fluorometry protocol were used to
compare DNA yields. A subset of this group, 94 DNA
samples (50 from blood and 44 from saliva), were se-
lected for microarray analysis. These included 23 pairs
of samples from which blood and saliva were obtained
from the same individual. The selection of the group of
94 samples was deliberately weighted to include thosehaving unusually high and low DNA concentrations,
along with some saliva DNAs that were unusually turbid
or discolored. UV absorption spectra from 220 to
340 nm and 260/280 and 260/230 absorbance ratios
were also obtained for this group, using a Nanodrop
ND-8000 spectrophotometer (Thermo Scientific, DE),
and protein contamination was measured directly with
the Qubit protein assay kit (cat # Q33211, Life Tech-
nologies, CA) with a Qubit 2.0 Fluorometer. The 1555
DNA samples chosen for sequencing comprised consecu-
tive samples from early February 2013 to late October
2015, spanning the time interval during which the
POAAGG study shifted from blood to saliva collection.
Microarray genotyping and PCR Sanger sequencing
Ninety-four DNA samples were genotyped in two separ-
ate batches using the HumanOmniExpress 24v1 bead
chip assay (Illumina, CA) on the Infinium platform by
Illumina FastTrack Services (Illumina, San Diego, CA).
The genotype calls were generated using the GenomeStu-
dio genotyping module (GT). Cluster optimization, repro-
ducibility analysis for paired samples, and data evaluation
were also performed as per standard practices at Illumina
FastTrack services. During cluster optimization 1822
markers were removed from 716,503 total markers on the
array.
Saliva DNAs were used as templates for PCR targeting
glaucoma-associated SNPs for two genes, TMCO1 and
CDKN2B-AS1. PCR was done in a reaction volume of
12 μl using Platinum Taq hot start DNA polymerase
(#106566-034, ThermoFisher.com), dNTP mix (# 18427-
088, ThermoFisher.com) and betaine (Sigma #B0300,
http://www.sigmaaldrich.com). Each PCR reaction con-
tained 1.2 μl of 10x Platinum Taq reaction buffer, 0.24 μl
of 10 mM dNTPs, 0.96 μl of 50 mM MgCl2 (4 mM
final), 2.4 μl of forward and reverse primer (2 pmol/μl),
3 μl saliva DNA, 0.096 μl Taq polymerase, 3.6 μl 5 M
betaine, and 0.5 μl nuclease-free water. For TMCO1,
1555 DNA samples were tested, using forward primer
ACCACAGGGAGCCTCTCGTT and reverse primer
GCCCTGCCTGCTTTTTAGGGA. For CDKN2B-AS1,
the same 1555 samples were tested, using forward pri-
mer GCGGAGAAGAATGTCCCGGC and reverse pri-
mer GCCAGGAAGGACGAGTCCCC. Thermal cycling
was performed on an ABI 9700 instrument using a
touchdown protocol: initial denaturation 95 deg C
5 min; 14 cycles: 94 deg 20 s, 63 deg to 56 deg with
0.5 deg decrement per cycle 20 s, 72 deg 45 s; 25 cycles:
94 deg 20 s, 56 deg 20 s, 72 deg 45 s; 72 deg 10 min;
final hold at 10 deg. PCR products were cleaned up by
digestion with shrimp alkaline phosphatase (SAP) and
exonuclease 1 (Exo1). Cycle sequencing reactions were
robotically assembled using a Biomek 3000 automated li-
quid handling system, with the BigDye Terminator v3.1
Fig. 1 Examples of saliva DNAs having visible impurities. Sample
S-2922 has a normal clear appearance, similar to DNAs extracted
from blood. The others have various degrees of turbidity and/or
brownish/reddish discoloration. Brownish saliva DNAs, S-3053 and
S-1829, may have come from specimens contaminated by tobacco,
food dyes or lipstick
Table 1 Demographic characteristics and DNA yields per






No. samples 566 2344
Age ± SD years 65 ± 12 65 ± 12 0.95
Female (%) 67.8 67.4 0.88
Mean ± SD for total DNA
yield per specimen (μg)
106 ± 68 35 ± 36 P < 0.0001
Mean ± SD for DNA yield
per ml of requested
specimen (μg/ml)
13.2 ± 8.5 17.6 ± 17.8 P < 0.0001
Specimen collection volume was up to 8 ml for blood and up to 2 ml
for saliva
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was done in a volume of 5 μl, containing 1.25 μl of a 4-
fold or 8-fold dilution of the SAP/Exo1 digested PCR
product, 1.25 μl sequencing primer (one of the PCR
primers) at 5 pmol/μl, and 2.5 μl diluted BigDye v3.1
Ready Mix. Sequencing reactions were cleaned up with
BigDye XTerminator kits (#4376485, ThermoFisher.-
com). Capillary electrophoresis was done on an ABI
3130xl genetic analyzer with 50 cm capillary array and
POP-7 polymer (#4363785, ThemoFisher.com), and se-
quencing chromatograms were aligned, trimmed and
scored using Sequencher 5.1 software (GeneCodes Corp,
genecodes.com).
Statistical analysis
Kernel density plots were created using the ggplot2
package in the R statistical package [23]. Comparisons
between blood samples and saliva samples were made
using t-tests for comparison of means and chi-squared
tests for comparison of proportions. For the comparison
of 23 paired samples with blood and saliva from the
same subjects, a paired t-test was used. An F-test was
used to test for equality of variance between two groups.
All these statistical comparisons were made using SAS
v9.3 (SAS Institute Inc., Cary, NC), and two-sided p < 0.05
was considered to be statistically significant. Sequencing
results from blood vs. saliva DNAs were compared using a
two-sided, two-sample proportion test with STATA v14.1
(StataCorp, College Station, TX).
Results and discussion
Quality and yield of DNA from saliva
The saliva samples from our predominately elderly study
population yielded DNAs that were often highly viscous,
with the majority having noticeable turbidity. Although
subjects had been asked to not eat or drink 30 min prior
to specimen donation, with the exception of placing a
small amount of sugar or sugar substitute on the tongue
to stimulate salivation when needed, visible contami-
nants such as food particles, lipstick, food coloring, to-
bacco, etc. were sometimes present in the saliva samples.
In some cases, brownish discoloration, suspected to be
tobacco-related, or reddish contamination (chewing
gum, candy, or lipstick) carried through processing and
were still visible in some of the purified DNA samples
(Fig. 1).
Two thousand three hundred forty-four saliva speci-
mens and 566 blood specimens were obtained, with both
blood and saliva specimen obtained from 23 people for
purposes of this study, and for a small number of indi-
viduals for whom the initial DNA extraction from blood
was not successful. The demographics of the two groups
of participants were very similar, with mean age 65 years
and approximately 68 % female (Table 1). The mean(±SD) total yield of DNA from the 2344 saliva specimens
was 35 ± 36 μg, as compared to the 106 ± 68 μg in the
566 blood specimens. However, after accounting for the
smaller specimen collection volume that was attempted
for saliva (2 ml) vs. blood (8 ml), the mean (±SD) yield
of DNA per ml saliva specimen was 17.6 ± 17.8 μg/ml,
which was significantly higher than that for blood speci-
mens (13.2 ± 8.5 ug/ml, p < 0.0001). The higher yield of
DNA per ml of saliva is necessarily offset by the pres-
ence of non-human DNA, which, as mentioned above,
has been addressed by other studies. A failure rate of
6.0 % (141 subjects from 2344 total) was observed for
saliva specimens, with failure defined as a final DNA
concentration that was below 10 ng/μl of DNA, which
corresponded to less than 2 μg yield in the minimum
elution volume (200 μl). There was a weak negative
correlation (Spearman correlation coefficient r = −0.1,
p < 0.0001) between subject age and DNA yield from
saliva samples whereas, the DNA yield from blood
was not correlated with age (r = 0.04, p = 0.30).
The total DNA yield distribution from the larger sub-
set of the POAAGG cohort (566 blood DNAs and 2344
saliva DNAs) was evaluated by the Quant iT assay, and
is illustrated as a kernel density plot in Fig. 2. The ma-
jority of saliva samples fall in the lower yield region of
the plot, as expected, whereas the yield from blood tubes
varies widely, with considerable overlap with the yield
from saliva, in spite of the 4-fold larger maximum
Fig. 2 Density plot summarizing 2910 total DNA yields that were
obtained from single blood (n = 566, 8 ml max) and saliva (n = 2344,
2 ml max) collection tubes
Fig. 3 Comparisons of UV absorbance of blood vs. saliva DNAs.
The average absorbance spectra of blood (n = 50) vs. saliva
specimens (n = 44) are compared (a), and the distributions of
260:280 absorbance ratios around each mean, indicated by
horizontal lines, are shown in (b)
Table 2 Characteristics of the 94 blood and saliva DNA samples
selected for genotyping






Blood (n = 50) 175.3 ± 163 1.91 ± 0.06 1.50 ± 0.57
Saliva (n = 44) 78.4 ± 91.5 1.71 ± 0.13 1.00 ± 0.30
P-value 0.0006 P < 0.0001 P < 0.0001
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blood. The distribution of DNA from saliva is relatively
narrow with a single peak, whereas the blood DNA dis-
tribution is broad and bimodal. Although exact speci-
men collection volumes were not recorded, we believe
this difference is because we often were unable to collect
a full 8 ml blood specimen for a substantial fraction of
our mostly elderly study population, whereas almost all
subjects succeeded in supplying the 2 ml saliva specimen
volume that was requested.
Among the 94 samples that were selected for micro-
array genotyping, average UV absorbance for the 44 sal-
iva DNA samples was higher than for the 50 blood DNA
samples across the range from 230 nm to 340 nm
(Fig. 3a). The higher absorbance at A230 nm may be due
to the presence of relatively large amounts of carbohy-
drates and heavily glycosylated mucin in the saliva sam-
ples, or sugar that had been given to ameliorate dry
mouth. The mean A260/280 ratio for saliva DNAs (1.71)
was significantly lower than for blood (1.91) (p < .0001,
Table 2, Fig. 3b). Furthermore, the A260/280 ratios for sal-
iva DNAs were much more variable than for blood
DNAs (p < 0.0001 for test of equal variance, Table 2,
Fig. 3b). The 94 DNA concentrations and quality data,
as measured by fluorescence and spectrophotometry are
shown in Additional file 1: Table S1, and summarized in
Table 2. It is important to note that the mean DNA con-
centration of the 44 saliva DNAs chosen for genotyping,
78.4 ng/μl, was more than 2-fold lower than for blood
(175.3 ng/μl) (p < 0.0001, Table 2). A minimum concen-
tration of 50 ng/μl is recommended for genotyping with
the OmniExpress array, so this study deliberately in-
cluded many saliva DNAs having sub-optimal concen-
trations for this purpose.
The turbidity of many DNAs obtained from saliva
(Fig. 1), together with the decreased 260/280 absorbanceratio for saliva DNA during spectrophotometry,
prompted us to evaluate protein contamination in the
94 DNAs that had been selected for microarray genotyp-
ing. Using the Qubit Protein assay, the protein concen-
trations was below the level of detection in 42 (84 %) of
blood samples and in 16 (36 %) of saliva samples (P <
0.0001, Additional file 1: Table S1). However, among
those with protein above the detectable level, we ob-
served no significant difference in the mean protein esti-
mation from blood (116 ± 54 ng/μl) versus saliva DNA
(119 ± 59 ng/μl).
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Surprisingly, the average genotyping call rates from the
Illumina HumanOmniExpress 24v1 bead chip assay for
blood and saliva DNAs were nearly identical: 99.62 vs
99.61 % from blood and saliva, respectively. The individ-
ual call rates for the 94 samples, along with age, gender,
concentrations and comments on physical appearance of
the DNA in solution after extraction are listed in
Additional file 1: Table S1. The majority (59 %) of these
subjects were age 65 or older. The genotyping call rates
are plotted for the two-genotyping batches, with source
tissues indicated, in Fig. 4a. If 98 % is considered the
minimum threshold for success, then only one outlying
sample, S-781 from saliva, failed; the paired blood DNA
collected from the same individual yielded a typical pass-
ing call rate (99.5 %). With the exception of this one
sample, all saliva DNAs yielded call rates > 99 %, whereas
the 2nd and 3rd worst performing samples in this survey
were blood DNAs (Fig. 4a). The genotype call rates were
slightly lower in batch 2, due to optimized clustering for
batch 1.Fig. 4 Comparison of genotyping call rates by Illumina Human OmniExpre
batches (a), and call rates are plotted versus DNA concentration (b). The fir
turbidity and/or abnormally low or high concentrations. The second batch
the same individualsThe relationship between genotyping call rate and
DNA concentration of the samples is plotted in Fig. 4b.
We observed genotyping call rates above 99 % on 92 of
94 samples, although the concentration of many was
below 10 ng/μl, less than 20 % of the minimum (50 ng/
μl) recommended for this assay. All low concentration
blood DNAs (<25 ng/μl) yielded call rates 99 % or
higher, whereas a low concentration (10.5 ng/μl) saliva
DNA, S-781 had the lowest call rate (97 %) (Additional
file 1: Table S1). The two worst performing blood sam-
ples, B-1898 and B-636 with call rates of 98.9 % and
99.0 %, had intermediate DNA concentrations 238 ng/μl
and 296 ng/μl, suggesting no discernable effect of DNA
concentration on the call rates for DNA from blood
throughout the tested range of ~10 to ~400 ng/μl. Al-
though all but one saliva DNA yielded call rates >99 %,
the worst performing saliva samples were clustered at
the lowest end of the concentration range (Fig. 4b).
However, the average call rate (99.68 %) for blood
DNAs, having concentrations ≤ 25 ng/μl, was only
slightly higher than for dilute saliva DNAs only
(99.45 %), and this difference is not significant (p = 0.08).ss microarrays. 94 DNAs from blood or saliva were genotyped in 2
st batch of samples was deliberately enriched for DNAs having visible
contained 23 paired specimens: both blood and saliva collected from
Fig. 5 Comparison of genotyping call rates on the Illumina Human OmniExpress microarrays for male (n = 46) vs. female (n = 48) subjects
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call rate for saliva DNAs (99.73 %) was actually higher
than blood DNAs (99.6 %) (p = 0.003). In general, our re-
sults are consistent with those of Bahlo et al. [17] who
concluded that genotyping with an Illumina platform
was generally robust for saliva DNAs, even though these
contain visible impurities and bacterial or other non-
human DNA.
Genotyping call rates were expected to be slightly
higher for males than females, due to the presence of Y
chromosome markers on the array. The difference in the
distributions between the genotyping call rates of males
vs females is noticeable on the kernel density plot in
Fig. 5, although this difference is small in absolute terms.
The mean genotyping call rates were 99.5 % for females
and 99.7 % for males.
Among 22 paired blood and saliva DNAs isolated from
the same individuals, their call rate agreed very well,
with a mean difference of 0.083 % (p = 0.46, paired t-
test). One pair of samples was removed from this geno-
typing concordance estimate on account of the extreme
outlier with low genotyping call rate of 97.35 %, saliva
sample (S-781), discussed above.
One thousand five hundred fifty-five of the saliva
DNAs were evaluated by PCR Sanger sequencing, target-
ing glaucoma-associated SNPs in or near the CDKN2B-
AS1 and TMCO1 genes. High quality Sanger sequencing
(Quality Value (QV) > 25, KB Basecaller) was obtained
for ≥ 98.0 % of these samples for CDKN2B-AS1 and
TMCO1 amplicons, from both blood (n = 297) and saliva
(n = 1258) DNAs, and these success rates did not differ
significantly (data not shown).Conclusion
Although DNAs extracted from saliva were inferior to
those from blood in terms of physical appearance and
standard measures of quality, their performance in
array-based genotyping was excellent, and nearly indis-
tinguishable from DNAs from blood. With the exception
of a single saliva DNA sample (1 of 44) having a low call
rate of 97.35 %, saliva-derived DNA samples yielded call
rates > 99 %, with genotyping results that were highly
concordant with blood DNA from the same subjects.
The mean concordance of genotyping calls from the
paired saliva-blood samples was at least 99.996 %
(Additional file 1: Table S1). Saliva specimens yielded a
minimum of 2 μg DNA at concentrations above 10 ng/μl
for 94 % of specimens (n = 2344 extractions). High quality
PCR Sanger sequencing data was obtained for ≥ 98 % of
blood and saliva DNAs in two independent high through-
put sequencing experiments (n = 1555 tested). Collec-
tion of saliva DNA has the potential to boost study
enrollments, thereby increasing the statistical power
of large population based studies such as the
POAAGG project, while decreasing the personnel ef-
fort and training required to obtain DNA samples of
adequate quality for microarray-based genotyping and
sequencing.
Additional file
Additional file 1: Table S1. Subject gender, age, DNA characteristics
and genotyping results corresponding to the samples used for
genotyping. (“B” sample IDs indicate DNA from blood and “S” sample
IDs are DNA from saliva). (DOCX 31 kb)
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